Union Ministers Dr Mansukh Mandaviya and Jitendra Singh launched inCOVACC, the Indian nasal vaccine today on the occasion of the…
iNCOVACC: Bharat Biotech in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose
The Centre on Tuesday approved the cost of Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which will be used as a…
Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.